S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Laser breakthrough could send stock soaring 2,467% (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
NASDAQ:CUTR

Cutera (CUTR) Stock Forecast, Price & News

$17.15
+0.19 (+1.12%)
(As of 06/2/2023 ET)
Compare
Today's Range
$16.84
$17.44
50-Day Range
$14.14
$27.07
52-Week Range
$13.21
$54.04
Volume
465,876 shs
Average Volume
943,195 shs
Market Capitalization
$340.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.75

Cutera MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
91.0% Upside
$32.75 Price Target
Short Interest
Bearish
22.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.71mentions of Cutera in the last 14 days
Based on 13 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.32) to ($1.77) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.54 out of 5 stars

Computer And Technology Sector

533rd out of 609 stocks

Electromedical Equipment Industry

19th out of 22 stocks


CUTR stock logo

About Cutera (NASDAQ:CUTR) Stock

Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

CUTR Stock News Headlines

Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Cutera Shareholder Action Reminder
Cutera Deadline Alert
See More Headlines

CUTR Price History

CUTR Company Calendar

Last Earnings
5/09/2023
Today
6/04/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CUTR
Employees
461
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$32.75
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+91.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-82,340,000.00
Pretax Margin
-36.31%

Debt

Sales & Book Value

Annual Sales
$252.40 million
Book Value
($1.97) per share

Miscellaneous

Free Float
19,418,000
Market Cap
$340.08 million
Optionable
Optionable
Beta
1.59

Social Links


Key Executives

  • Sheila A. Hopkins
    Chief Executive Officer & Director
  • Stuart Drummond
    Chief Financial Officer, VP & Corporate Controller
  • Michael Karavitis
    Chief Technology Officer & Executive VP
  • Charles Guy Thier
    Chief Information Officer
  • Vikram Kalidindi Varma
    Senior VP, Compliance Officer & General Counsel













CUTR Stock - Frequently Asked Questions

Should I buy or sell Cutera stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CUTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CUTR, but not buy additional shares or sell existing shares.
View CUTR analyst ratings
or view top-rated stocks.

What is Cutera's stock price forecast for 2023?

5 equities research analysts have issued twelve-month price objectives for Cutera's stock. Their CUTR share price forecasts range from $14.00 to $50.00. On average, they anticipate the company's stock price to reach $32.75 in the next twelve months. This suggests a possible upside of 91.0% from the stock's current price.
View analysts price targets for CUTR
or view top-rated stocks among Wall Street analysts.

How have CUTR shares performed in 2023?

Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR shares have decreased by 61.2% and is now trading at $17.15.
View the best growth stocks for 2023 here
.

Are investors shorting Cutera?

Cutera saw a increase in short interest in May. As of May 15th, there was short interest totaling 4,460,000 shares, an increase of 6.7% from the April 30th total of 4,180,000 shares. Based on an average daily volume of 817,600 shares, the short-interest ratio is presently 5.5 days.
View Cutera's Short Interest
.

When is Cutera's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CUTR earnings forecast
.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) announced its earnings results on Tuesday, May, 9th. The medical device company reported ($1.26) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.96. The medical device company earned $55 million during the quarter, compared to analyst estimates of $59.80 million. Cutera had a negative trailing twelve-month return on equity of 489.05% and a negative net margin of 36.98%. The business's revenue was down 5.2% on a year-over-year basis. During the same period last year, the firm posted ($0.84) earnings per share.

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.86%), RTW Investments LP (9.31%), FMR LLC (7.35%), Gamco Investors INC. ET AL (5.68%), State Street Corp (4.03%) and First Light Asset Management LLC (2.87%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea.
View institutional ownership trends
.

How do I buy shares of Cutera?

Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $17.15.

How much money does Cutera make?

Cutera (NASDAQ:CUTR) has a market capitalization of $340.08 million and generates $252.40 million in revenue each year. The medical device company earns $-82,340,000.00 in net income (profit) each year or ($4.81) on an earnings per share basis.

How many employees does Cutera have?

The company employs 461 workers across the globe.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.

This page (NASDAQ:CUTR) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -